phenyl-n-tert-butylnitrone and Huntington Disease

phenyl-n-tert-butylnitrone has been researched along with Huntington Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brundin, P; Grasbon-Frodl, EM; Nakao, N; Widner, H1

Other Studies

1 other study(ies) available for phenyl-n-tert-butylnitrone and Huntington Disease

ArticleYear
DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease.
    Neuroscience, 1996, Volume: 74, Issue:4

    Topics: Acetylcholinesterase; Animals; Brain Tissue Transplantation; Cyclic N-Oxides; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Fetal Tissue Transplantation; Graft Survival; Huntington Disease; Motor Skills; Neostriatum; Nerve Tissue Proteins; Nitrogen Oxides; Phosphoproteins; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Spin Labels

1996